Clinical Trial Update: Evaluation of the Tolerance, Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of MIL62 Injection for Treating Lupus Nephritis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MIL62 injection in lupus nephritis reporting tolerance, safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy in Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• MIL62

Snippet

Sponsor: Beijing Mabworks Biotech Co., Ltd. | Conditions: Lupus Nephritis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING